Recombinant zoster vaccine vs placebo
Participants with adverse events ‐ serious adverse events Clinical or laboratory criteria · healthy older adults aged ≥ 60 years
Recombinant zoster vaccine showed no clear difference in participants with adverse events ‐ serious adverse eventsClinical or… compared with placebo (moderate certainty).
1 finding from 1 review
- RR 0.97 [0.91, 1.03]2 studies · 29311 participantsModerate